Trial Outcomes & Findings for Humeral Shaft Pseudoarthrosis Treated With Bone Autograft Versus Platelet Rich Plasma (NCT NCT02520089)

NCT ID: NCT02520089

Last Updated: 2018-07-30

Results Overview

The evaluation of the radiographic extent of the bony callus (consolidation grade) will be assessed via anteroposterior and lateral radiograph of the arm and classified in different levels, as follows: * Grade 0, no identifiable bony callus . * Grade 1, primary bony callus formation with little or no new periosteal bone. * Grade 2, new periosteal bone formation on two sides of the humerus. * Grade 3, new periosteal bone formation on three or four sides of the humerus.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

9th month

Results posted on

2018-07-30

Participant Flow

Participant milestones

Participant milestones
Measure
Bone Autograft
The investigator it will obtain bone autograft of iliac crest ipsilateral of each patient. And apply into the pseudoarthrosis focus at the moment of the fixation with a locking compression plates. bone autograft of iliac crest: The investigators will take bone autograft of iliac crest of the patient and then apply into the site of pseudoarthrosis, this graft have osteogenic, osteoinductive and osteoconductive properties
Platelet Rich Plasma Plus Bone Autograft
Other group of patients it will be extracted 40 mL of peripheric blood sample, and processed with a double-centrifugation technique to obtain 5 mL of platelet rich plasma, and collocated into the focus of pseudoarthrosis after standard fixation with locking compression plates and Bone Autograft of Iliac Crest. Platelet Rich Plasma plus bone autograft: Sample of 40 mL of peripheric blood and processed to obtain 5 mL of platelet rich plasma, and collocated into pseudoarthrosis
Overall Study
STARTED
12
11
Overall Study
COMPLETED
9
7
Overall Study
NOT COMPLETED
3
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Bone Autograft
The investigator it will obtain bone autograft of iliac crest ipsilateral of each patient. And apply into the pseudoarthrosis focus at the moment of the fixation with a locking compression plates. bone autograft of iliac crest: The investigators will take bone autograft of iliac crest of the patient and then apply into the site of pseudoarthrosis, this graft have osteogenic, osteoinductive and osteoconductive properties
Platelet Rich Plasma Plus Bone Autograft
Other group of patients it will be extracted 40 mL of peripheric blood sample, and processed with a double-centrifugation technique to obtain 5 mL of platelet rich plasma, and collocated into the focus of pseudoarthrosis after standard fixation with locking compression plates and Bone Autograft of Iliac Crest. Platelet Rich Plasma plus bone autograft: Sample of 40 mL of peripheric blood and processed to obtain 5 mL of platelet rich plasma, and collocated into pseudoarthrosis
Overall Study
Lost to Follow-up
3
4

Baseline Characteristics

Humeral Shaft Pseudoarthrosis Treated With Bone Autograft Versus Platelet Rich Plasma

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Bone Autograft
n=9 Participants
The investigator it will obtain bone autograft of iliac crest ipsilateral of each patient. And apply into the pseudoarthrosis focus at the moment of the fixation with a locking compression plates. bone autograft of iliac crest: The investigators will take bone autograft of iliac crest of the patient and then apply into the site of pseudoarthrosis, this graft have osteogenic, osteoinductive and osteoconductive properties
Platelet Rich Plasma Plus Bone Autograft
n=7 Participants
Other group of patients it will be extracted 40 mL of peripheric blood sample, and processed with a double-centrifugation technique to obtain 5 mL of platelet rich plasma, and collocated into the focus of pseudoarthrosis after standard fixation with locking compression plates and Bone Autograft of Iliac Crest. Platelet Rich Plasma plus bone autograft: Sample of 40 mL of peripheric blood and processed to obtain 5 mL of platelet rich plasma, and collocated into pseudoarthrosis
Total
n=16 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
7 Participants
n=7 Participants
16 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
38.8 years
STANDARD_DEVIATION 15.3 • n=5 Participants
37.1 years
STANDARD_DEVIATION 10.2 • n=7 Participants
38.1 years
STANDARD_DEVIATION 12.9 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
5 Participants
n=7 Participants
13 Participants
n=5 Participants
Region of Enrollment
Mexico
9 Participants
n=5 Participants
7 Participants
n=7 Participants
16 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 9th month

The evaluation of the radiographic extent of the bony callus (consolidation grade) will be assessed via anteroposterior and lateral radiograph of the arm and classified in different levels, as follows: * Grade 0, no identifiable bony callus . * Grade 1, primary bony callus formation with little or no new periosteal bone. * Grade 2, new periosteal bone formation on two sides of the humerus. * Grade 3, new periosteal bone formation on three or four sides of the humerus.

Outcome measures

Outcome measures
Measure
Bone Autograft
n=9 Participants
The investigator it will obtain bone autograft of iliac crest ipsilateral of each patient. And apply into the pseudoarthrosis focus at the moment of the fixation with a locking compression plates. bone autograft of iliac crest: The investigators will take bone autograft of iliac crest of the patient and then apply into the site of pseudoarthrosis, this graft have osteogenic, osteoinductive and osteoconductive properties
Platelet Rich Plasma Plus Bone Autograft
n=7 Participants
Other group of patients it will be extracted 40 mL of peripheric blood sample, and processed with a double-centrifugation technique to obtain 5 mL of platelet rich plasma, and collocated into the focus of pseudoarthrosis after standard fixation with locking compression plates and Bone Autograft of Iliac Crest. Platelet Rich Plasma plus bone autograft: Sample of 40 mL of peripheric blood and processed to obtain 5 mL of platelet rich plasma, and collocated into pseudoarthrosis
Stans Scale
2.7 units on a scale
Standard Deviation 0.5
3.0 units on a scale
Standard Deviation 0.0

SECONDARY outcome

Timeframe: 9th months

It is designed to measure physical function and symptoms in patients with any or several musculoskeletal disorders of the upper limb. Where the better evaluation is equal to 0, and the worst evaluation is equal to 100.

Outcome measures

Outcome measures
Measure
Bone Autograft
n=9 Participants
The investigator it will obtain bone autograft of iliac crest ipsilateral of each patient. And apply into the pseudoarthrosis focus at the moment of the fixation with a locking compression plates. bone autograft of iliac crest: The investigators will take bone autograft of iliac crest of the patient and then apply into the site of pseudoarthrosis, this graft have osteogenic, osteoinductive and osteoconductive properties
Platelet Rich Plasma Plus Bone Autograft
n=7 Participants
Other group of patients it will be extracted 40 mL of peripheric blood sample, and processed with a double-centrifugation technique to obtain 5 mL of platelet rich plasma, and collocated into the focus of pseudoarthrosis after standard fixation with locking compression plates and Bone Autograft of Iliac Crest. Platelet Rich Plasma plus bone autograft: Sample of 40 mL of peripheric blood and processed to obtain 5 mL of platelet rich plasma, and collocated into pseudoarthrosis
Quick Disability of Arm, Shoulder and Hand
7.28 units on a scale
Standard Deviation 11.3
5.32 units on a scale
Standard Deviation 8.23

Adverse Events

Bone Autograft

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Platelet Rich Plasma Plus Bone Autograft

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Carlos Alberto Acosta-Olivo

Universidad Autonoma de Nuevo Leon

Phone: +528183476698

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place